Kumar Amarjeet, Sinha Chandni, Kumari Poonam, Kumar Ajeet, Sinha Amit Kumar, Kumar Bindey
Department of Trauma and Emergency, AIIMS, Patna, Bihar, India.
Department of Anaesthesia, AIIMS, Patna, Bihar, India.
Indian J Anaesth. 2020 Nov;64(11):949-953. doi: 10.4103/ija.IJA_813_20. Epub 2020 Nov 1.
Ultrasound guided rhomboid intercostal plane block (RIB) is a relatively new regional anaesthesia technique that has shown to provide dermatomal coverage from T2-9 on the whole anterior and posterior hemithorax. It has proved effective in providing preemptive analgesia in various surgeries like mastectomy and thoracotomy. The aim of the study was to study the efficacy of RIB in paediatric patients: 7 to 12 years undergoing thoracoscopic surgeries in terms of analgesic requirement, pain scores and adverse effects.
In this randomised, prospective double-blind study, 40 American Society of Anesthesiologists I/II patients, of the age group 7-12 years scheduled for Video-assisted thoracoscopy (VATS) surgery were recruited. The patients were allocated to one of the two groups: group R: general anaesthesia + RIB (RIB group) and group F: general anaesthesia (FENT group). Perioperative opioid consumption and postoperative pain scores were recorded. Adverse effects like respiratory depression and nausea were also noted.
Patients in group R required less intraoperative fentanyl dose (1.45 ± 0.65 vs 2.90 ± 0.45) ( < 0.05). Postoperative opioid consumption was also less in this group R (2.90 ± 0.91 vs 5.56 ± 1.08) ( < 0.05). Less number of patients experienced nausea (2 vs 6) and respiratory depression (2 vs 7) in group R.
Ultrasound guided RIB reduces perioperative opioid consumption in patients undergoing VATS surgery with lesser postoperative pain scores.
超声引导下菱形肌肋间平面阻滞(RIB)是一种相对较新的区域麻醉技术,已显示可提供T2 - 9节段对整个前胸壁和后胸壁的皮节覆盖。它已被证明在乳房切除术和开胸手术等各种手术中提供超前镇痛有效。本研究的目的是研究RIB在7至12岁接受胸腔镜手术的儿科患者中的疗效,包括镇痛需求、疼痛评分和不良反应。
在这项随机、前瞻性双盲研究中,招募了40例年龄在7 - 12岁、计划行电视辅助胸腔镜(VATS)手术的美国麻醉医师协会I/II级患者。患者被分配到两组之一:R组:全身麻醉 + RIB(RIB组)和F组:全身麻醉(芬太尼组)。记录围手术期阿片类药物的消耗量和术后疼痛评分。还记录了呼吸抑制和恶心等不良反应。
R组患者术中所需芬太尼剂量较少(1.45 ± 0.65 vs 2.90 ± 0.45)(<0.05)。R组术后阿片类药物消耗量也较少(2.90 ± 0.91 vs 5.56 ± 1.08)(<0.05)。R组经历恶心(2例 vs 6例)和呼吸抑制(2例 vs 7例)的患者数量较少。
超声引导下的RIB可减少接受VATS手术患者的围手术期阿片类药物消耗量,术后疼痛评分更低。